These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1956560

  • 1. AL amyloidosis: therapeutic response in two patients with renal involvement.
    Goddard IR, Jackson R, Jones JM.
    Nephrol Dial Transplant; 1991; 6(8):592-4. PubMed ID: 1956560
    [No Abstract] [Full Text] [Related]

  • 2. Primary systemic amyloidosis: resolution of the nephrotic syndrome with melphalan and prednisone.
    Kyle RA, Wagoner RD, Holley KE.
    Arch Intern Med; 1982 Aug; 142(8):1445-7. PubMed ID: 7103624
    [Abstract] [Full Text] [Related]

  • 3. Treatment of AL amyloidosis with melphalan, prednisone, and colchicine.
    Benson MD.
    Arthritis Rheum; 1986 May; 29(5):683-7. PubMed ID: 3718560
    [Abstract] [Full Text] [Related]

  • 4. Therapy of primary amyloidosis with melphalan and prednisone.
    Schwartz RS, Cohen JR, Schrier SL.
    Arch Intern Med; 1979 Oct; 139(10):1144-7. PubMed ID: 485747
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.
    Skinner M, Anderson J, Simms R, Falk R, Wang M, Libbey C, Jones LA, Cohen AS.
    Am J Med; 1996 Mar; 100(3):290-8. PubMed ID: 8629674
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Resolution of primary amyloidosis during chemotherapy. Studies in a patient with nephrotic syndrome.
    Cohen HJ, Lessin LS, Hallal J, Burkholder P.
    Ann Intern Med; 1975 Apr; 82(4):466-73. PubMed ID: 1119764
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Remission of nephrotic syndrome in amyloidosis of familial Mediterranean fever following colchicine treatment.
    Odabas H.
    Ann Saudi Med; 2006 Apr; 26(2):157-8. PubMed ID: 16761461
    [No Abstract] [Full Text] [Related]

  • 13. Regression of nephrotic syndrome in amyloidosis of familial mediterranean fever following colchicine treatment.
    Livneh A, Shtrasburg S, Langevitz P.
    Nephrol Dial Transplant; 2000 Oct; 15(10):1713-4. PubMed ID: 11007856
    [No Abstract] [Full Text] [Related]

  • 14. [Amyloidosis in a mixed pattern. Sensitivity to colchicine and melphalan].
    Frustaci A, Gentiloni N, Feoli F.
    Minerva Med; 1981 Apr 14; 72(15):957-60. PubMed ID: 6784038
    [Abstract] [Full Text] [Related]

  • 15. Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of the literature.
    Gertz MA, Kyle RA.
    Mayo Clin Proc; 1986 Mar 14; 61(3):218-23. PubMed ID: 3945122
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Is colchicine therapy effective in all patients with secondary amyloidosis?
    Unverdi S, Inal S, Ceri M, Unverdi H, Batgi H, Tuna R, Ozturk MA, Guz G, Duranay M.
    Ren Fail; 2013 Sep 14; 35(8):1071-4. PubMed ID: 23841746
    [Abstract] [Full Text] [Related]

  • 20. A patient with multiple myeloma, amyloidosis and light-chain deposition disease in kidneys with a long survival.
    Christou L, Hatzimichael EC, Sotsiou-Candila F, Siamopoulos K, Bourantas KL.
    Acta Haematol; 1999 Sep 14; 101(4):202-5. PubMed ID: 10436302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.